Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
The life sciences investment firm Deerfield Management has signed its first international agreement, pledging up to $130 million over 10 years to a collaboration with Yeda Research and Development, the commercial arm of Israel’s Weizmann Institute of Science. The new company, Orchard Innovations, will develop medicines based on Weizmann research. This is Deerfield’s second recent academic partnership in as many months. In December, the firm entered a similar $130 million pact with Duke University.
This article has been sent to the following recipient: